Daqing B. Wang
Dalian, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Metabolic reprogramming of cholesterol biosynthesis drives macrophage-mediated immune suppression in HPV-negative cervical adenocarcinoma.
Journal: Frontiers in immunology
Published: February 10, 2026
Role of mesenchymal stem cells and their derived exosomes in cervical cancer: Bidirectional mechanisms and research progress (Review).
Journal: Oncology letters
Published: February 04, 2026
The global clinical landscape of human-derived extracellular vesicles: an analysis based on ClinicalTrials.gov (2010-2025).
Journal: Clinical and experimental medicine
Published: December 02, 2025
Single-Cell Transcriptomics Reveals Biomarkers for NK Cell Dysfunction in Endometriosis-Associated Immune Dysregulation.
Journal: Mediators of inflammation
Published: October 09, 2025
Single-Cell Transcriptomics Reveals Biomarkers for NK Cell Dysfunction in Endometriosis-Associated Immune Dysregulation.
Journal: Mediators of inflammation
Published: October 09, 2025
Single-Cell Transcriptomics Reveals Biomarkers for NK Cell Dysfunction in Endometriosis-Associated Immune Dysregulation.
Journal: Mediators of inflammation
Published: October 09, 2025
Mapping the global clinical landscape of NK cell therapies for solid tumors: an analysis based on the ClinicalTrials.gov for the 2005-2024 period.
Journal: Journal of cancer research and clinical oncology
Published: August 19, 2025
Role of NTRK Fusion Genes in the Tumor Immune Microenvironment of HPV (+/-) Cervical Cancer.
Journal: Journal of medical virology
Published: May 08, 2025
Practice guideline for the treatment and management of iatrogenic premature ovarian insufficiency.
Journal: Maturitas
Published: January 27, 2025
Prognostic factors and survival outcomes of immunohistochemically detection based-molecular subtypes of endometrial cancer-analysis of 576 clinical cases.
Journal: Diagnostic pathology
Published: November 05, 2024
Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023.
Journal: Human vaccines & immunotherapeutics
Published: October 16, 2024
CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges.
Journal: Biomolecules
Published: June 14, 2024
Last Updated: 09/26/2026